Myalgic Encephalomyelitis treatment and research
This pack has been prepared ahead of the debate to be held in Westminster Hall on Thursday 21 June 2018 at 1.30pm on Myalgic Encephalomyelitis treatment and research. The subject for the debate has been selected by the Backbench Business Committee and the debate will be opened by Carol Monaghan MP.
A debate on Myalgic Encephalomyelitis: Treatment and Research will take place in Westminster Hall on 21 June 2018. The debate will be led by Carol Monaghan MP.
There has been recent debate on a number of issues relating to treatment and research for Myalgic Encephalomyelitis (ME). These have included calls for improved awareness of this condition and greater provision of services and specialist care. Following a recent review, clinical guidelines on the diagnosis and management of this condition are currently being updated.
Both the type and funding of research undertaken into this condition is also an issue that has been raised recently. Charities and campaigners report that funding is significantly less than for conditions with a similar prevalence and disease burden.[1]
[1] ME Association, Action for M.E., ME Trust and #ME action, Parliamentary briefing for Carol Monaghan MP’s debate on Myalgic Encephalomyelitis Treatment and research, 12 June 2018